SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

JP Morgan Maintains Overweight on 10x Genomics, Raises Price Target to $95

JP Morgan maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $90 to $95.

Benzinga · 05/12/2020 14:23

JP Morgan maintains 10x Genomics (NASDAQ:TXG) with a Overweight and raises the price target from $90 to $95.